NR4A1 and breast carcinoma: Furthermore, ERK5 is more highly expressed in breast cancer cells and tumor tissue compared to normal breast cells and tissue (11), and has elevated expression in the more clinically aggressive breast cancer subtype, triple negative breast cancer (TNBC), compared to hormone receptor positive breast cancers (10–12).